⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
MoonLake Immunotherapeutics (MLTX) Faces Securities Fraud Allegations Over Drug Trial Results - Investors Are Notified to Contact BFA Law by December 15 Deadline
accessnewswire.com
MLTX
MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
prnewswire.com
MLTX
Investors in MoonLake Immunotherapeutics (MLTX): Protect Your Rights - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
Class Action Filed Against MoonLake Immunotherapeutics (MLTX) Over Securities Violations - Contact Levi & Korsinsky Today
accessnewswire.com
MLTX
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at MoonLake Immunotherapeutics
businesswire.com
MLTX
The Gross Law Firm Notifies Shareholders of MoonLake Immunotherapeutics(MLTX) of a Class Action Lawsuit and an Upcoming Deadline
prnewswire.com
MLTX
SueWallSt Podcast Explains Class Action Against MoonLake Immunotherapeutics (MLTX)
accessnewswire.com
MLTX
Lost Money on MoonLake Immunotherapeutics (MLTX)? Join Class Action Before December 15, 2025 - Contact Levi & Korsinsky
accessnewswire.com
MLTX
Pomerantz LLP Alerts Shareholders to Investor Suit Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
MLTX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX